Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Hepatic ketogenic insufficiency reprograms hepatic glycogen metabolism and the lipidome
D. André d’Avignon, … , Xianlin Han, Peter A. Crawford
D. André d’Avignon, … , Xianlin Han, Peter A. Crawford
Published June 21, 2018
Citation Information: JCI Insight. 2018;3(12):e99762. https://doi.org/10.1172/jci.insight.99762.
View: Text | PDF
Research Article Hepatology Metabolism

Hepatic ketogenic insufficiency reprograms hepatic glycogen metabolism and the lipidome

  • Text
  • PDF
Abstract

While several molecular targets are under consideration, mechanistic underpinnings of the transition from uncomplicated nonalcoholic fatty liver disease (NAFLD) to nonalcoholic steatohepatitis (NASH) remain unresolved. Here we apply multiscale chemical profiling technologies to mouse models of deranged hepatic ketogenesis to uncover potential NAFLD driver signatures. Use of stable-isotope tracers, quantitatively tracked by nuclear magnetic resonance (NMR) spectroscopy, supported previous observations that livers of wild-type mice maintained long term on a high-fat diet (HFD) exhibit a marked increase in hepatic energy charge. Fed-state ketogenesis rates increased nearly 3-fold in livers of HFD-fed mice, a greater proportionate increase than that observed for tricarboxylic acid (TCA) cycle flux, but both of these contributors to overall hepatic energy homeostasis fueled markedly increased hepatic glucose production (HGP). Thus, to selectively determine the role of the ketogenic conduit on HGP and oxidative hepatic fluxes, we studied a ketogenesis-insufficient mouse model generated by knockdown of the mitochondrial isoform of 3-hydroxymethylglutaryl-CoA synthase (HMGCS2). In response to ketogenic insufficiency, TCA cycle flux in the fed state doubled and HGP increased more than 60%, sourced by a 3-fold increase in glycogenolysis. Finally, high-resolution untargeted metabolomics and shotgun lipidomics performed using ketogenesis-insufficient livers in the fed state revealed accumulation of bis(monoacylglycero)phosphates, which also accumulated in livers of other models commonly used to study NAFLD. In summary, natural and interventional variations in ketogenesis in the fed state strongly influence hepatic energy homeostasis, glucose metabolism, and the lipidome. Importantly, HGP remains tightly linked to overall hepatic energy charge, which includes both terminal fat oxidation through the TCA cycle and partial oxidation via ketogenesis.

Authors

D. André d’Avignon, Patrycja Puchalska, Baris Ercal, YingJu Chang, Shannon E. Martin, Mark J. Graham, Gary J. Patti, Xianlin Han, Peter A. Crawford

×

Figure 2

Ketogenesis-insufficient mice exhibit augmented glycogen-sourced hepatic glucose production.

Options: View larger image (or click on image) Download as PowerPoint
Ketogenesis-insufficient mice exhibit augmented glycogen-sourced hepatic...
(A) βOHB production quantified using hepatic venous effluent from 60-minute portal vein perfusions using oxygenated buffers containing 0.2 mM unlabeled sodium octanoate and 3% 2H2O, in the absence (–) or presence (+) of sodium [U-13C]propionate (0.2 mM) or insulin (10 μU/ml). (B) βOHB production in the absence (–) or presence (+) of sodium octanoate (0.2 mM) from 60-minute portal vein perfusions using oxygenated buffers. The first 2 bars on the left are presented for comparison and represent the same data as those presented in the middle 2 bars in panel A. (C) Glucose production, (D) glycogenolysis flux, (E) glycerol-supported flux to gluconeogenesis, and (F) phosphoenolpyruvate–supported (PEP-supported) flux to gluconeogenesis quantified as described for panel A. (G) Relative contributions of glycogen, glycerol, and PEP to hepatic glucose production, derived from data presented in panels C–F. (H) Hepatic glycogen concentrations in random-fed (collected at 10 am) mice. n = 6–13/group. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. ns, not significant by 2-way ANOVA with Tukey’s or Bonferroni’s post hoc test, or Student’s t test as appropriate. Boxed values correspond to the effect of 10 μU/ml insulin in the presence of [13C]propionate, compared with the absence of insulin in the presence of [13C]propionate. ND, none detected.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts